Divisions Faculty Industry Pharmacoengineering and Molecular Pharmaceutics,
Grayson MendenhallNovember 16, 2007
Oriel Therapeutics, an inhaled drug-delivery company cofounded by UNC School of Pharmacy professor Anthony Hickey, PhD, has received a $26.5 million commitment from a group of venture capital firms.
The commitment comes from a group led by New Leaf Partners, a New York venture capital firm. The money will fund the company’s development of drugs that use its patented dry-powder inhaler technology, which was developed at the School.
Based in Research Triangle Park, Oriel was founded in 2001 and holds four U.S. patents. It began as a company that develops inhalers for use with other companies’ medicine, but has since started developing its own drugs.
Media reports about the venture financing:
- News & Observer: Oriel wins $26.5 million pledge to develop drugs
- Triangle Business Journal: Oriel $23M richer; firm brings in new chairman
Latest News

Featured, Featured News, Grants and Awards, News, Sidebar Featured News, Students
School set to offer immersive STEM enrichment program to high school students in Eastern and Western North Carolina

Education, Featured, Featured News, News, Sidebar Featured News
NCCU joins School’s Early Assurance Program

Featured News, News, Sidebar Featured News, Students